InvestorsHub Logo
Followers 0
Posts 213
Boards Moderated 0
Alias Born 07/31/2017

Re: None

Thursday, 05/10/2018 4:04:53 PM

Thursday, May 10, 2018 4:04:53 PM

Post# of 18220
Food for thought-Eli Lilly just announced about 3 hours ago that it is buying for $1.6 Billion cash Armo BioSciences. Armo has a lead drug pegilodecakin that is the cytokine IL-10 and is in late stage clinical testing in pancreatic cancer and activates CD8+ T Cells. This cytokine has been tested on its own and in combination with chemotherapies and could very well be useful in combination therapy with a different immunotherapy.

Remember methionine enkephalin (MENK) anyone?